Rebecca B. Scarr, Ph.D.

Associate

Rebecca Scarr focuses her practice on drafting and prosecuting patent applications, interferences, opinions, and client counseling for both domestic and international clients. She specializes in molecular biology, cellular biology, biochemistry, and biotechnology.

Dr. Scarr began as a patent agent with Finnegan in April 2001.

Highlights

• Performed research at MIT focusing on mammalian transcription and the role of Host Cell Factor-1 in mammalian cells.
• At Harvard, she studied cytosine-5-methyltransferases and the mechanism of DNA methylation.
• As an undergraduate at MIT, she conducted research related to the chemical synthesis of peptides and RNA.
• Former research assistant with a biotechnology company, where she conducted primary research related to small molecule/RNA interactions.

Select Publications

• “Process Patent Protection: Section 337 Investigations and the Safe Harbor Defenses of § 271(G),” 337 Reporter, Summer Associate Edition, 2003-2004.
• Coauthor. “PDCD2 is a Negative Regulator of HCF-1 (C1),” Oncogene, 2002.
• Coauthor. “A Novel 50-Kilodalton Fragment of Host Cell Factor 1 (C1) in G(0) Cells,” Molecular Cellular Biology, 2000.
• Coauthor. “DNA-Dependent RNA Polymerase from Enterobacter Cloacae is Closely Related to Escherichia Coli,” International Journal of Biochemical Cellular Biology, 2000.
• Coauthor. “Improved Synthesis and Aminoacylation of P-Nitrobenzophenone Oxime Polystyrene Resin for Solid-Phase Synthesis of Protected Peptides,” Peptide Research, 1990.